The Globe and Mail reports in its Tuesday, Jan. 23, edition that RBC Dominion Securities analyst Drew McReynolds has reaffirmed his "outperform" recommendation for Thomson Reuters. The Globe's David Leeder writes in the Eye On Equities column that Mr. McReynolds's share target soared $16 to $149 (all figures U.S.). Analysts on average target the shares at $138.06. Mr. McReynolds believes "the bar to deliver consolidated organic revenue growth in excess of 6 per cent has quickly risen driven incrementally by growth-accretive M&A and GenAI monetization." Mr. McReynolds says in a note: "We believe current valuation levels are fundamentally justified provided: (I) management meets or exceeds this growth trajectory without meaningful changes to the company's current margin, capex and FCF conversion profile; (ii) solid execution on the GenAI playbook continues with little change to the current GenAI narrative including perceived opportunities and risks; and (iii) the valuation impact of lower interest rate expectations/bond yields at worst is neutral. Thomson Reuters remains a high-quality, core holding in our coverage capable of generating average annual total returns of 10 to 15 per cent over the long-term."